Mar 08, 2018
As part of FDA initiatives to reward innovation and promote patient access to medicines, the agency is working hard to support the development of high quality biosimilars and interchangeable products, Scott Gottlieb told a conference on March 7.
Mar 07, 2018
Pharmaceutical Executive
The public and policymakers seek more transparency in pricing and product development.
Feb 26, 2018
Adhering to new compliance legislation such as Identification of Medicinal Products (IDMP) can bring a pharma company benefits as well as challenges, writes Darren Cooper.
Feb 14, 2018
Advocates on all sides applauded the request to increase funding significantly for FDA under the Trump administration’s budget for fiscal year 2019.
Feb 08, 2018
Commissioner Scott Gottlieb this week outlined FDA plans to continue the fight against opioid addiction and to prepare a “comprehensive plan” to bolster the market for biosimilars.
Feb 06, 2018
Pharmaceutical Executive
Low-cost follow-ons and biosimilars please payers but heighten competitive battles with brands.
Feb 01, 2018
In his State-of-the-Union address this week, President Trump continued his harangue about unfair drug prices in the U.S., but he surprised many observers by failing to call for full repeal of the Affordable Care Act.
Jan 24, 2018
Reflector reports on the EU's legislative move to push the fifty or so national and regional HTA organizations in Europe towards greater cooperation.
Jan 10, 2018
If confirmed as the next secretary of the Department of Health and Human Services (HHS), Alex Azar says that a top priority is to make drugs more affordable.
Dec 31, 2017
Enacting landmark tax reform legislation that makes major changes in the corporate tax structure was Congress's Christmas present to President Trump — and to industry, writes Jill Wechsler.
lorem ipsum